Immune Stimulation Flashcards
conditions where immune modulation is the goal
immune deficiency, chronic infection, chemo, immunological disorders (MS), cancer, myelogenous blood disorders
antigen specific modulators
active and passive immunization
non-antigen specific modulators
adjuvants (BCG, cytokines, alum, liposomes), macrophage activation, cytokines (IL-2, IFNs), passive immunoglobulins (monoclonal Abs), and drugs
filgrastim
G-CSF stimulating factor (neutrophils); used for neutropenia or in conjunction with chemotherapy
filgrastim dosing
injectable
filgrastim side effects
fever, cough, bone pain, reactions at injection site; severe effects are splenic rupture, sickle cell crisis, acute respiratory distress
IFN-alpha2a, 2b (type I IFNs)
help with viral infections like hepatitis C; recombinant human proteins that are administered weekly (IM or subQ)
type I IFN mechanism
act by inducing IFN-sensitive genes with different antiviral activities, direct effect on viral replication, indirectly elicits T cell response
type I IFN side effects
injection site reaction, flu-like symptoms, depression, breathing problems, leukopenia, neutropenia
epoetin alpha
EPO; can be used for anemia; increases level of RBCs
epoetin alpha dosing
injected 3 times weekly
epoetin alpha side effects
hypertension, headaches, thrombotic events, sensitivity reactions, stroke, death
contraindications for epoetin alpha
bone-marrow based cancers and acute myelogenous leukemia
aldesleukin (IL-2)
immunostimulant that can be used in cases of metastasis
IL-2 mechanism
recombinant human IL-2; must be closely managed during and post IV infusion; induces proliferation of T cells and enhances effector functions